UK Drug update

Published: 27-Aug-2001
Regulatory


Abbott Laboratories has marketed Uprima sublingual tablets. The product contains 2mg or 3mg of the D2-dopaminergic agonist apomorphine hydrochloride.

Amgen has introduced Aranesp injection containing the anti-anaemic drug darbepoetin alfa in the following strengths: 10, 15, 20, 30, 40, 50, 60, 80, 100 and 150µg.

Generics (UK) has added 150 mg tablets of the antidepressant trazodone to its product range. The company has also brought out a sugar-free suspension of the antibiotic erythromycin in three strengths: 125mg/ml, 250mg/ml and 500mg/ml.

Bioglan Generics has introduced 20mg and 40mg tablets of the H2-blocker famotidine.

Faulding Pharmaceuticals has brought out 15mg/5ml, 30mg/10ml, 60mg/10ml and 90mg/10ml vials containing the biphosphonate pamidronate disodium.

Crookes Healthcare Thas made available a maximum strength formulation of its nonsteroidal anti-inflammatory product Nurofen Gel, containing 10% ibuprofen.

Lagap Pharmaceuticals has launched 0.5mg tablets of the anti-psychotic drug, haloperidol.

Straken has introduced Demestril-Septem patches. The product, a once-weekly patch containing the oestrogen, oestradiol, delivers 25µg oestradiol per 24h (Demestril-Septem 25), 50µg oestradiol/24h (Demestril-Septem 50) or 75µg oestradiol/24 h (Demestril-Septem 75).

Axcan Pharma has marketed Photofrin injection containing 15mg or 75mg of the cytotoxic porfimer sodium as powder for injection.

Alcon Laboratories has made available Tobradex eye-drops containing 0.3% w/v of the corticosteroid dexamethasone.

AstraZeneca has marketed Symbicort Turbohaler. The anti-asthma product contains budesonide and formoterol fumarate in 100/6 and 200/6 ratios.

Genus Pharmaceuticals has introduced the antibiotic ceftriaxone in 1g vial and 2g infusion formulations.

See more

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

Read more
New SOLAR CEMNEX analyser offers advanced compliance and connectivity features

Trending Articles

  1. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste
  2. Balancing innovation and accessibility in amino acid testing Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Quality management during manufacturing changes: part I Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
  4. NICE recommends enfortumab vedotin with KEYTRUDA for adults in England/Wales with untreated metastatic urothelial cancer The results from the Phase III study EV-302/KN-A39 showed nearly a doubling of survival rates in patients compared with those who received platinum-based chemotherapy, which is the current standard of care in the UK
  5. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Manufacturing

Signal Group launches MCERTS approved VOC emissions monitor

New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Cloud labelling and serialisation: the new frontline of traceability in drug delivery

As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
Regulatory

Novo Nordisk’s oral semaglutide scores EU approval for cardiovascular benefits

Rybelsus is now the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke
Manufacturing

Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision

Partnership delivers compliance confidence, efficiency gains and reduced waste
Regulatory

New NICE thresholds: good news for rare disease drugs but process remains complex

Recent changes introduced by NICE will ultimately see more ultra-rare disease drugs get to market, but Dan Williams, CEO at SynaptixBio, says the process remains challenging
Manufacturing

Balancing innovation and accessibility in amino acid testing

Butterworth Laboratories expands analytical capabilities to support compliance with Ph. Eur. standards
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Quality management during manufacturing changes: part I

Change is a universal constant and continues to accelerate in the realms of pharmaceutical, medical device and in-vitro diagnostic manufacturers who face ever-increasing pressure to optimise costs while maintaining high product quality and patient safety standards
Subscribe now